- Home
- FBYD vs RPTX Comparison
FBYD vs RPTX Comparison
Compare FBYD & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBYD
- RPTX
- Stock Information
- Founded
- FBYD 2021
- RPTX 2016
- Country
- FBYD United States
- RPTX Canada
- Employees
- FBYD N/A
- RPTX N/A
- Industry
- FBYD
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- FBYD
- RPTX Health Care
- Exchange
- FBYD Nasdaq
- RPTX Nasdaq
- Market Cap
- FBYD 120.8M
- RPTX 141.1M
- IPO Year
- FBYD N/A
- RPTX 2020
- Fundamental
- Price
- FBYD $9.19
- RPTX $1.46
- Analyst Decision
- FBYD
- RPTX Strong Buy
- Analyst Count
- FBYD 0
- RPTX 3
- Target Price
- FBYD N/A
- RPTX $7.00
- AVG Volume (30 Days)
- FBYD 29.0K
- RPTX 569.3K
- Earning Date
- FBYD 02-01-2025
- RPTX 11-07-2024
- Dividend Yield
- FBYD N/A
- RPTX N/A
- EPS Growth
- FBYD N/A
- RPTX N/A
- EPS
- FBYD N/A
- RPTX N/A
- Revenue
- FBYD $7,530,000.00
- RPTX $66,524,000.00
- Revenue This Year
- FBYD N/A
- RPTX $13.22
- Revenue Next Year
- FBYD N/A
- RPTX N/A
- P/E Ratio
- FBYD N/A
- RPTX N/A
- Revenue Growth
- FBYD N/A
- RPTX 18.19
- 52 Week Low
- FBYD $5.85
- RPTX $1.47
- 52 Week High
- FBYD $13.25
- RPTX $8.49
- Technical
- Relative Strength Index (RSI)
- FBYD 54.31
- RPTX 30.68
- Support Level
- FBYD $8.51
- RPTX $2.97
- Resistance Level
- FBYD $9.76
- RPTX $4.07
- Average True Range (ATR)
- FBYD 0.92
- RPTX 0.34
- MACD
- FBYD 0.11
- RPTX -0.17
- Stochastic Oscillator
- FBYD 29.26
- RPTX 0.38
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has five operating segments, Falcon's Creative Group, PDP, Sierra Parima, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.